GH Latest Press Releases

-- October 20, 2026 --

Guardant Health Highlights Broad Liquid Biopsy Research Portfolio at ESMO Congress 2026 Business Wire 9:02 AM

-- October 15, 2026 --

TwinStrand Biosciences Announces Second U.S. Patent Trial and Appeal Board Decision Upholding All Claims of TwinStrand's '127 Patent Business Wire 4:01 PM

Guardant Health Shield Blood Test Demonstrates Leading Screening Adherence and CRC Deaths Averted Compared to Stool-Based Tests Business Wire 8:05 AM

-- October 8, 2026 --

Guardant Health Announces Approval in Europe of Guardant360 CDx as Companion Diagnostic for AstraZeneca's ETCAMAH (camizestrant) in Advanced ER-positive Breast Cancer Business Wire 4:12 PM

Guardant Health to Report Third Quarter 2026 Financial Results on November 5, 2026 Business Wire 4:05 PM

-- October 5, 2026 --

Guardant Health COSMOS Study Published in Cancer Research Communications Validates Utility of Guardant Reveal Liquid Biopsy Test for Predicting Recurrence in Melanoma Business Wire 11:27 AM

-- September 14, 2026 --

Guardant Health's Shield Blood Test Covered by EviCore by Evernorth for Colorectal Cancer Screening Business Wire 4:05 PM

-- September 9, 2026 --

Guardant Health and Collaborators to Present 20 Abstracts Highlighting Portfolio of Liquid Biopsy Tests for Early Detection and Ongoing Treatment Management at 2026 World Conference on Lung Cancer Business Wire 3:46 PM

-- September 8, 2026 --

Business Insider Names Guardant Health One of America's Most Innovative Businesses Business Wire 2:38 PM

-- September 4, 2026 --

Guardant Health Announces Landmark FDA Approval of Guardant360 CDx as Companion Diagnostic for AstraZeneca's ETCAMAH (camizestrant) in Advanced Breast Cancer Business Wire 6:10 PM

-- September 1, 2026 --

Guardant Health's Shield Blood Test Covered by Carelon Health Services for Colorectal Cancer Screening Business Wire 8:05 AM

-- August 24, 2026 --

Guardant Health to Appeal Federal District Court Judgment Business Wire 2:44 PM

TwinStrand Biosciences Announces Final Judgment in Patent Infringement Suit Against Guardant Health, Awarding TwinStrand and the University of Washington More Than $245.2 Million in Damages, Accrued Royalties and Interest Business Wire 7:00 AM

-- August 10, 2026 --

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:05 PM

-- July 30, 2026 --

Guardant Health Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance Business Wire 4:05 PM

-- July 29, 2026 --

Guardant Health to Participate in Upcoming Investor Conferences Business Wire 4:05 PM

-- July 28, 2026 --

Actor and Cancer Advocate Patrick Dempsey Stars in Emotional Tribute Video From Guardant Health Memorializing Those Who Have Lost Their Lives to Colorectal Cancer Business Wire 7:13 AM

-- July 9, 2026 --

Guardant Health to Report Second Quarter 2026 Financial Results on July 30, 2026 Business Wire 4:05 PM

-- July 1, 2026 --

UnitedHealth Group Now Covers Guardant Health's Shield Blood Test for Colorectal Cancer Screening Business Wire 2:50 PM

-- June 11, 2026 --

Guardant Health Announces FDA Approval of Guardant360 CDx as Companion Diagnostic for Boehringer Ingelheim's HERNEXEOS Business Wire 8:05 AM

-- May 28, 2026 --

Guardant Health and Collaborators to Present 38 Abstracts Highlighting Breadth and Expanded Clinical Utility of Guardant Liquid Biopsy Tests Powered by InfinityAI at 2026 ASCO Annual Meeting Business Wire 8:05 AM

-- May 27, 2026 --

American Cancer Society Recommends Guardant Health's Shield Blood Test in Updated Colorectal Cancer Screening Guidelines Business Wire 7:48 AM

Market Data Delayed 15 Minutes